drugset / Trial / NCT03576599
Intravenous Bisphosphonate in Stress Fracture Treatment -A Randomised Controlled Double Blinded Multicenter Trial
Phase 4
Terminated
5 enrolled
Oslo University Hospital
Betanien Hospital · collabSykehuset Ostfold · collab
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The effect of an intravenous bisphosphonate (zoledronic acid) on healing and symptoms of stress fractures that do not respond to conservative/conventional treatment within 6 months, will be investigated.
Timeline
- Start
- 2017-06-29
- Primary completion
- 2019-06-26
- Completion
- 2019-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Zoledronic acid | Other / unclassified | 5 mg | Intravenous |